Mallinckrodt plc
http://www.mallinckrodt.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Mallinckrodt plc
Finance Watch: Certain Offerings Find Their Way To Investors In Tough Market
Public Company Edition: The stock market has been unkind to biotech firms but investors rewarded some drug developers for clinical trial successes, including Scholar Rock and Day One, which raised $205m and $172.5m, respectively. However, some SPAC deals and an IPO never got off the ground.
Keeping Track: US FDA Okays Alnylam’s siRNA Amvuttra, Alopecia Claim For Lilly’s Olumiant; Sierra Submits Momelotinib
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
New Biosimilars Council Head Seeks Insulin Lessons As More Biosimilar Launches Loom
Craig Burton, who replaces the FDLI-bound Christine Simmon, tells the Pink Sheet that fighting rebating practices which harm insulin patients now can pave the way for successful launches of Humira biosimilars next year. Biosimilar markets should not be ‘winner-take-all,’ he says.
Upstream Launches With $200m To Buy, Develop Drugs For Immune-Mediated Diseases
Upstream Bio acquired Phase Ib-ready UPB-101 from Astellas, and its experienced team plans to buy additional drug candidates for the treatment of allergic and inflammatory diseases.
Company Information
- Industry
- Medical Devices
-
Pharmaceuticals
- Generic Drugs
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Aspect Medical Systems, Inc.
- BÂRRX Medical, Inc.
- Cadence Pharmaceuticals, Inc.
- CNS Therapeutics, Inc.
- ev3 Inc.
- Given Imaging Ltd.
- Ikaria Holdings, Inc.
- InfaCare Pharmaceutical Corporation
- INO Therapeutics, LLC
- Mallinckrodt Inc.
- Mallinckrodt Pharmaceuticals
- Micro Therapeutics, Inc.
- Nellcor Puritan Bennett, Inc.
- Ocera Therapeutics Inc. (OCRX)
- Oridion Systems Ltd.
- Questcor Pharmaceuticals, Inc.
- Somanetics Corp.
- Sonorant Inc.
- SpecGx Inc.
- Sucampo Pharmaceuticals, Inc.(SCMP)
- VNUS Medical Technologies
- Stratatech Corporation
- Tranzyme Pharma